IRF1 and neoplasm: Included within these analyses were the TNM staging, Milan-UCSF criteria, tumor microemboli, BRCA1 (low/high group), p53 (negative/positive group), Ki-67 (positive rate of Ki-67 detection in nuclei) and IRF-1 (negative/positive group).